(AVY) Avery Dennison - Overview
Sector: Consumer Cyclical | Industry: Packaging & Containers | Exchange: NYSE (USA) | Market Cap: 12.212m USD | Total Return: -10.1% in 12m
Avg Turnover: 110M
EPS Trend: 90.4%
Qual. Beats: 0
Rev. Trend: 92.2%
Qual. Beats: 1
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Avery Dennison Corporation is a global materials science company specializing in pressure-sensitive adhesive materials and digital identification solutions. Its portfolio includes label materials, performance tapes, and reflective films used across the automotive, retail, and pharmaceutical sectors. The company operates through established brands such as Fasson, JAC, and Mactac, providing critical components for branding, information labeling, and supply chain logistics.
The business model relies on high-volume manufacturing of substrates and adhesives, increasingly integrating Radio Frequency Identification (RFID) technology to enable digital tracking for apparel and logistics providers. As a leader in the Paper & Plastic Packaging sector, the company benefits from the global shift toward e-commerce and the rising demand for intelligent packaging solutions that enhance inventory visibility. For a deeper look at the company’s valuation metrics, consider reviewing the data on ValueRay.
Headquartered in Mentor, Ohio, Avery Dennison maintains an extensive international footprint with operations spanning North America, Europe, Asia, and Latin America. Beyond traditional labeling, the firm provides branding embellishments and compliance solutions for the global apparel industry, as well as functional films for architectural and transportation safety applications.
- RFID adoption expansion in retail and logistics drives high-margin digital identification growth
- Raw material cost fluctuations in paper and plastic films impact consolidated operating margins
- Global consumer packaging demand fluctuations dictate pressure-sensitive label volume and revenue
- Strategic acquisitions in intelligent labeling solutions accelerate portfolio transition toward high-growth segments
| Net Income: 689.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.64 > 1.0 |
| NWC/Revenue: 4.66% < 20% (prev 0.89%; Δ 3.77% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.03b > Net Income 689.8m |
| Net Debt (3.54b) to EBITDA (1.46b): 2.42 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.0m) vs 12m ago -3.02% < -2% |
| Gross Margin: 28.76% > 18% (prev 0.29%; Δ 2.85k% > 0.5%) |
| Asset Turnover: 103.9% > 50% (prev 104.8%; Δ -0.85% > 0%) |
| Interest Coverage Ratio: 8.00 > 6 (EBITDA TTM 1.46b / Interest Expense TTM 140.1m) |
| A: 0.05 (Total Current Assets 3.22b - Total Current Liabilities 2.80b) / Total Assets 8.98b |
| B: 0.64 (Retained Earnings 5.71b / Total Assets 8.98b) |
| C: 0.13 (EBIT TTM 1.12b / Avg Total Assets 8.67b) |
| D: 0.81 (Book Value of Equity 5.44b / Total Liabilities 6.68b) |
| Altman-Z'' = 4.10 = AA |
| DSRI: 1.05 (Receivables 1.65b/1.52b, Revenue 9.01b/8.75b) |
| GMI: 1.00 (GM 28.76% / 28.79%) |
| AQI: 1.04 (AQ_t 0.47 / AQ_t-1 0.45) |
| SGI: 1.03 (Revenue 9.01b / 8.75b) |
| TATA: -0.04 (NI 689.8m - CFO 1.03b) / TA 8.98b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 159.66 with a total of 341,598 shares traded.
Over the past week, the price has changed by +2.21%,
over one month by -3.53%,
over three months by -18.74% and
over the past year by -10.07%.
Avery Dennison has received a consensus analysts rating of 4.45. Therefore, it is recommended to buy AVY.
- StrongBuy: 7
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 200.3 | 25.5% |
P/E Forward = 15.361
P/S = 1.3561
P/B = 5.2833
P/EG = 1.7639
Revenue TTM = 9.01b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.46b USD
Long Term Debt = 3.19b USD (from longTermDebt, last quarter)
Short Term Debt = 605.0m USD (from shortTermDebt, last quarter)
Debt = 3.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.54b USD (calculated: Debt 3.79b - CCE 255.1m)
Enterprise Value = 15.7b USD (12.2b + Debt 3.79b - CCE 255.1m)
Interest Coverage Ratio = 8.00 (Ebit TTM 1.12b / Interest Expense TTM 140.1m)
EV/FCF = 18.04x (Enterprise Value 15.7b / FCF TTM 872.9m)
FCF Yield = 5.54% (FCF TTM 872.9m / Enterprise Value 15.7b)
FCF Margin = 9.69% (FCF TTM 872.9m / Revenue TTM 9.01b)
Net Margin = 7.66% (Net Income TTM 689.8m / Revenue TTM 9.01b)
Gross Margin = 28.76% ((Revenue TTM 9.01b - Cost of Revenue TTM 6.42b) / Revenue TTM)
Gross Margin QoQ = 28.92% (prev 28.65%)
Tobins Q-Ratio = 1.75 (Enterprise Value 15.7b / Total Assets 8.98b)
Interest Expense / Debt = 3.70% (Interest Expense 140.1m / Debt 3.79b)
Taxrate = 30.07% (72.3m / 240.4m)
NOPAT = 784.0m (EBIT 1.12b * (1 - 30.07%))
Current Ratio = 1.15 (Total Current Assets 3.22b / Total Current Liabilities 2.80b)
Debt / Equity = 1.65 (Debt 3.79b / totalStockholderEquity, last quarter 2.30b)
Debt / EBITDA = 2.42 (Net Debt 3.54b / EBITDA 1.46b)
Debt / FCF = 4.05 (Net Debt 3.54b / FCF TTM 872.9m)
Total Stockholder Equity = 2.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.96% (Net Income 689.8m / Total Assets 8.98b)
RoE = 30.81% (Net Income TTM 689.8m / Total Stockholder Equity 2.24b)
RoCE = 20.67% (EBIT 1.12b / Capital Employed (Equity 2.24b + L.T.Debt 3.19b))
RoIC = 11.56% (NOPAT 784.0m / Invested Capital 6.78b)
WACC = 6.79% (E(12.2b)/V(16.0b) * Re(8.09%) + D(3.79b)/V(16.0b) * Rd(3.70%) * (1-Tc(0.30)))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.45 | Cagr: -2.23%
[DCF] Terminal Value 77.97% ; FCFF base≈760.3m ; Y1≈871.6m ; Y5≈1.28b
[DCF] Fair Price = 206.2 (EV 19.3b - Net Debt 3.54b = Equity 15.8b / Shares 76.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.44 | EPS CAGR: 10.02% | SUE: 0.56 | # QB: 0
Revenue Correlation: 92.19 | Revenue CAGR: 2.56% | SUE: 1.61 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.47 | Chg30d=-4.45% | Revisions=-60% | Analysts=10
EPS next Quarter (2026-09-30): EPS=2.50 | Chg30d=-1.35% | Revisions=-56% | Analysts=10
EPS current Year (2026-12-31): EPS=10.02 | Chg30d=-1.02% | Revisions=-60% | GrowthEPS=+5.1% | GrowthRev=+4.7%
EPS next Year (2027-12-31): EPS=11.17 | Chg30d=-1.26% | Revisions=-60% | GrowthEPS=+11.4% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: -60%